According to Penumbra's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.54489. At the end of 2023 the company had a P/S ratio of 9.17.
Year | P/S ratio | Change |
---|---|---|
2023 | 9.17 | -8.04% |
2022 | 9.97 | -30.54% |
2021 | 14.4 | 26.63% |
2020 | 11.3 | 7.95% |
2019 | 10.5 | 11.05% |
2018 | 9.46 | -1.15% |
2017 | 9.57 | 24.8% |
2016 | 7.67 | -11.31% |
2015 | 8.65 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Merit Medical MMSI | 3.56 | -52.83% | ๐บ๐ธ USA |
Inari Medical
NARI | 4.95 | -34.45% | ๐บ๐ธ USA |